Guest guest Posted April 18, 2005 Report Share Posted April 18, 2005 To the Editors of the Washington Times: When I first read industry voice, Sullum's " Why can't NOW keep its hands off women's breasts? " in Reason Magazine, I noticed his 'titillating' title. To me, he epitomizes " if they can get you asking the wrong questions, they don't have to worry about the answers. " To the corporate world it appears, the health and protection of women and their breasts is not an issue for a national woman's organization. Odd that. " Breast implant pirouette " indeed 'spins' the real question regarding breast implants before the FDA right now. " Are silicone breast implants 'safe?' " The FDA was not given dominion over providing unsafe and unproven 'choices' to women. Nor do they have any obligation to provide a selection (choice) of questionable breast enhancements to the public. It's domain is over 'safety' ... not choice. Although Mr. Sullum credits NOW's Ms Gandy for 'raising the specter' on various cancers, in fact, it was the National Cancer Institute. I quote: " when they compared the risks for the implant patients with the general population, they found that the implant patients were two to three times more likely to develop stomach cancer, leukemia, and cancers of the cervix, vulva and brain. Eleven cases of brain tumors among the implant patients were identified on death certificates as the cause of death compared to one case in the plastic surgery control group. " http://www.cancer.gov/newscenter/silicone-othercancers Unfortunately, the high percentage of suicides occuring after ruptured breast implants has now been widely reported in the British Medical Journal and others. How can these facts be ignored or minimized? There is no 'oops factor' or 'recall' if down the road we 'nay sayers' are indeed correct in our safety concerns. Inamed has already been involved in one fiasco that requiring removing thousands of soybean filled implants in Britain that had been marketed from the United States. http://bankrupt.com/CAR_Public/000918.MBX And what is the rush? Every woman post mastectomy already has the 'choice' of silicone breast implants as do women who are replacing their failed implants. There are on-going studies for those that agree to be followed up and tested later. No promise of " FDA safety approval " are required for these. The FDA has a duty to maintain it's 'gold standard' of safety ... not provide a golden goose for the plastic surgeons and manufacturers. Please don't ask the FDA to tell " sweet little lies " -- that simply isn't their job. Ilena Rosenthal Director, Humantics Foundation www.BreastImplantAwareness.org ~~~~~~~~~~~~~~~~~ See below if anyone else wants to respond ... this has been published two places I've found so far ... Reason and the Wash Times with differing titles. To write Editors of Reason: Gillespie@... ,cpf@... The author: jsullum@... http://www.reason.com/sullum/041505.shtml Pro-Choice No More Why can't NOW keep its hands off women's breasts? Sullum Gillespie@... ,cpf@... Breast implant pirouette To respond: http://washingtontimes.com/contact-us/ Then click " letters to the editor " http://washingtontimes.com/commentary/20050417-114026-2064r.htm By Sullum For decades, members of the National Organization for Women and other groups that support abortion rights urged politicians to " keep your hands off our bodies. " Today, women who want to enhance their appearance with silicone breast implants can justly turn this slogan against NOW, which is pro-choice on abortion but anti-choice on cosmetic surgery. NOW President Kim Gandy says the controversy over whether the Food and Drug Administration should allow wider use of silicone breast implants, currently limited mainly to reconstructive surgery following mastectomies, is about " science and medicine. " But while science can tell us (in theory) what risks implants pose, it cannot tell us if they are justified. Different women will answer that question differently, depending upon their values, tastes and circumstances. In sharp contrast with its position on abortion, however, NOW argues women should not be allowed to do that. Ms. Gandy says women who want augmentation surgery cannot make an informed choice between silicone and saline implants until there is more research. This wait-and-see stance may seem reasonable. It was clear from the deliberations of the FDA's advisory committee, which recently recommended approval of one manufacturer's implants for general use but called for more information about the long-term performance of another's, that legitimate questions remain about how well the current models hold up after the first few years. But the determination of how much information women need to make a choice is itself a value judgment. Mentor, the company whose implant found favor with the advisory committee, reported a cumulative rupture rate of 0.8 percent among about 1,000 patients over three years. Based on longer-term studies by other researchers, it estimated 9 percent to 15 percent would experience ruptures after 12 years. NOW says Mentor should wait until the company's own 10-year study is completed. But that would mean women willing to accept the risk and uncertainty in exchange for the superior look and feel of silicone implants (preferred by 9 in 10 patients in countries where silicone implants are widely available) could not make that tradeoff. In any case, NOW's objections to silicone implants extend far beyond well-established local complications such as implant rupture, infection, inflammation and collapse of the scar-tissue capsule surrounding the implant. The group continues lending credence to the unsubstantiated fears of systemic illness that led to FDA's 1992 decision to limit sales of silicone implants. " Hundreds of thousands of women have been injured and become seriously ill after receiving silicone gel breast implants, " says Ms. Gandy in a December 2004 article on NOW's Web site. The article explains " breast implant patients report a variety of immune disorders such as rheumatoid arthritis, scleroderma, fibromyalgia, Sjogren's disease and lupus. " Ms. Gandy brags of being " informed by the personal stories of these survivors. " The problem is such stories don't prove anything, relying on emotion and post hoc, ergo propter hoc reasoning instead of scientific evidence. In a comprehensive 2000 report on the safety of silicone breast implants, the National Academy of Sciences concluded " silicone implants do not cause major disease. " As the New York Times notes, " Nearly all studies have found no link between silicone implants and serious disease. " Yet NOW encourages the belief research will one day " conclusively demonstrate that silicone gel should never be introduced into the human body, " as Ms. Gandy said in 2003. In addition to immune disorders, NOW raises the specter of lung cancer, brain cancer, suicide and harm to fetuses and nursing children. It throws in " rashes, hair loss, open sores, aching muscles and joints, mental confusion and memory loss " for good measure. Given the many charges and the difficulty teasing out small risks from epidemiological research, NOW's demand for " complete information " on silicone implants will never be met. In practice, it is the same as a demand for a permanent ban. Why doesn't NOW apply the same impossible standard to abortion, which has its share of complications and side effects, both known and hypothesized? I hesitate to suggest a nonscientific explanation, but perhaps it's because NOW -- which complains of " slick advertising campaigns " that manipulate women into getting boob jobs and dresses its activists in T-shirts declaring their breasts " 100 percent all natural " -- would prefer certain choices not be made at all. Sullum is a senior editor at Reason magazine, and his work appears in the new Reason anthology " Choice " (BenBella Books). Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.